SchizophreniaImagingNCT01409109
Database Registry for Neural Network Biomarkers in Psychosis
An observational study of Schizophrenia and Schizoaffective Disorder, run by University of Texas Southwestern Medical Center at 1 site in United States.
Trial summary
Several observations have been made with magnetic resonance imaging (MRI) that characterize brain connections and brain function in individuals with schizophrenia and other mental disorders. Read more about this study
- Who is it for?
- Ages 18 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Schizophrenia, Schizoaffective Disorder
- How many people
- 1,000 participants
- Where
- 1 siteUnited States
- Study dates
- Mar 2010to Apr 2029
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: Individuals who have been diagnosed with the following disorders will be enrolled in this study: Schizophrenia and Schizoaffective disorder.
Who may be able to join
- Volunteers with Schizophrenia or other mental illness
- Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) diagnosis of Schizophrenia or Schizoaffective disorder
- Competent to give informed consent
- All races and ethnicities
- Eyesight corrected to 20-40 or better
- Able to read, speak, and understand English
Show all 11Show fewer
- Healthy volunteers
- No past or current severe mental illness
- All races and ethnicities
- Eyesight corrected to 20-40 or better
- Able to read, speak, and understand English
Who cannot join
- Volunteers with schizophrenia or other mental illness
- Diagnosis of an organic brain disease
- Diagnosis of DSM-IV-TR alcohol or substance abuse within the last month or DSM-IV-TR alcohol or substance dependence within the last three months
- Serious, unstable medical illness
- History of serious head injury
- Pregnant women
Show all 13Show fewer
- Healthy volunteers
- History of psychiatric illness
- Current use of psychoactive drugs excluding nicotine and caffeine
- Diagnosis of an organic brain disease
- Serious, unstable medical illness
- History of serious head injury
- Pregnant women
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas, 75390
Elena Ivleva, M.D., Ph.D., 214-645-8942, elena.ivleva@utsouthwestern.edu
Debra Bushong, M.S., L.P.C., 214-648-4653 ext. Bushong, debra.bushong@utsouthwestern.edu
About this study
Official title: Database Registry to Examine Brain Connections and Brain Function in Mental Disorders and Neural Network Biomarkers for Relational Memory and Psychosis in Schizophrenia
Several observations have been made with magnetic resonance imaging (MRI) that characterize brain connections and brain function in individuals with schizophrenia and other mental disorders. For example, research investigating schizophrenia focuses on the dysfunction of connections within and between the medial temporal lobe and the prefrontal cortex as well as other pertinent brain regions. This database registry will allow for the collection of clinical interview data, behavioral data, blood, magnetic resonance imaging (MRI) data, and functional magnetic resonance imaging (fMRI) data on individuals with and without mental disorders to better understand how connections in the brain and various brain regions function differently while volunteers perform various cognitive tasks. This is an observational study that is being conducted to collect data and place it in a registry for current and future investigational questions related to imaging in mental disorders.
Read the detailed description
The proposed project entails the collection of clinical interview data, behavioral data, blood, magnetic resonance imaging (MRI) data, and functional magnetic resonance imaging (fMRI) data from 1000 volunteers, both patient volunteers and healthy normal volunteers. These data will be used for current and future investigations to better understand how the brains of those with mental disorders process differently that brains of healthy volunteers. The volunteers will undergo a series of clinical interviews to determine their diagnosis, behavioral task training, medical workup, and standard structural and functional magnetic resonance imaging. No changes will be made to the patient volunteers' medications or treatment regimes as part of the study. Data will be collected for all volunteer groups based on their performance on a variety of computer-mediated cognitive tasks. The volunteers will be trained to criteria on the tasks, at which point they will have the option to complete the MRI and fMRI portions of the study. Standard and functional MR images of the entire brain will be acquired while volunteers perform cognitive tasks thought to activate the medial temporal lobe and other pertinent brain regions. While participating in the task portion of the fMRI, visual stimulation (images) will be presented via back-projection from a high-resolution video projector (Epson 7000 series) with adjustable zoom. Volunteers will be asked to push a button on a handheld button box to record their responses as learned during training. For the non-task, resting portions of the fMRI, volunteers will be asked to stay relaxed and alert. In conjunction with one of the fMRI scans we will also conduct a cerebral blood volume (CBV) MRI to investigate blood perfusion in the medial temporal lobe of volunteers with mental illness to compare to normal control volunteers.
The proposed project will evaluate brain connectivity during cognitive tasks, including novelty detection, encoding and retrieval of associations between individual stimuli, and during other cognitive tasks thought to produce abnormal fMRI activations in volunteers with mental disorders. One example of a cognitive task is conducted as follows. Volunteers are shown a series of one-syllable nouns and asked to internally associate a second noun to the presented word (e.g. "station" to the presented word "train"). They press a response button when they have made a successful word association. Subsequently, volunteers are presented with a mixture of the previously encoded words and a new set of one-syllable nouns. Volunteers press one response button for previously presented words and another button for novel (new) words. fMRI scans for both parts of this task are acquired in the time between stimulus presentation and the press of the button. In another example of a cognitive task, volunteers are shown a novel series of faces paired with names and are instructed to remember the name for each face. In a subsequent period, volunteers attempt to remember which name goes to which face. The fMRI scans are acquired during both encoding and retrieval of the face-name pairs. These two described tasks are representative of the tasks to be used in terms of their difficulty and the effort required of the volunteers. In addition, "resting" and "control" tasks will be used to establish a baseline of brain activity against which we may then compare activity during our task of interest. Volunteers will receive instructions on task performance and will practice tasks prior to scanning in order to eliminate the novelty of the task itself as a potential confound. While the appointment time for a scan may take several hours, the volunteer will be in the scanner between 60 and 120 minutes depending on the specific memory task that is being administered at that visit. Any volunteer may receive training and be scanned on more than one task, but no volunteer will be kept in the scanner for longer than 120 minutes in any given session. Volunteers may also be asked to undergo one or two 60-minute MR Spectroscopy scans conducted on the 3Tesla (3T) or 7Tesla (7T) scanner. In this scan we will measure the levels of different brain compounds, such as neurotransmitters (e.g. glutamate, gamma aminobutyric acid [GABA]) or endogenous brain metabolites (e.g., N-acetyl -aspartate)in various brain regions, to non-invasively study tissue biochemistry.
- Conditions
- Schizophrenia, Schizoaffective Disorder
- Keywords
- Schizophrenia, Schizoaffective, Neuroimaging, Magnetic Resonance Imaging (MRI), Functional Magnetic Resonance Imaging (fMRI), Spectroscopy
- Medical subject headings
- Schizophrenia, Psychotic Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Patient volunteers | This group is comprised of persons with Schizophrenia and Schizoaffective. | |
| Healthy volunteers | This group is comprised of individuals who have no current or past psychiatric diagnosis. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Differences in hippocampal subfield activation between people with schizophrenia (or schizoaffective disorder) and healthy volunteers
This study will investigate the alterations in the medial temporal lobe, specifically the differences in hippocampal subfield activation, between patients with psychosis (Schizophrenia and Schizoaffective disorder), their relatives and normal volunteers. We hypothesize that there will be an increase in perfusion and a decrease in subfield activation in the people with psychosis.
Measured: Participants will be assessed over the course of 4-6 weeks, until all study procedures are complete
Secondary outcomes (1)
Differences in glutamate neurotransmitters and glutamatergic function between people with schizophrenia (or schizoaffective disorder) and with healthy volunteers
We aim to measure glutamate-related neurochemical profiles in schizophrenia using proton magnetic resonance spectroscopy (MRS) 7T. We will measure several brain metabolites, including glutamate, glutamine, GABA, glycine, N-acetylaspartyl-glutamate, glutathione, and myo-inositol, in addition to other major signals in brain MRS (i.e., N-acetylaspartate, creatine and choline), in anterior cingulate cortex (ACC) and dorsolateral prefrontal cortex (DLPFC) in volunteers with schizophrenia (SZ) and normal volunteers (NV).
Measured: Participants will be assessed over the course of 4-6 weeks, until all study procedures are complete
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Aug 2011 (estimated)
- Study startMar 2010
- Primary completionApr 2029 (estimated)
- Study completionApr 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SchizophreniaStudies of the same condition, open and under way.
- More trials run by University of Texas Southwestern Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute of Mental Health (NIMH)
- Responsible party
- Principal investigator, Carol A. Tamminga, University of Texas Southwestern Medical Center
- Investigators
- Carol A. Tamminga, M.D., Principal investigator, UT SouthwesternElena Ivleva, M.D., Ph.D., Principal investigator, UT Southwestern
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01409109
- Sponsor's protocol ID
- STU 062010-095
- Other IDs
- 1R01MH083957-01A2, 1K23MH102656-01A1
- Acronym
- Imaging
- Status last verified
- Apr 2026
- First submitted
- 29 Jun 2011
- Last updated
- 23 Apr 2026
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 23 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Database Registry to Examine Brain Connections and Brain Function in Mental Disorders and Neural Network Biomarkers for Relational Memory and Psychosis in Schizophrenia
- ClinicalTrials.gov ID
- NCT01409109
- Acronym / sponsor ID
- Imaging / STU 062010-095
- Conditions
- Schizophrenia, Schizoaffective Disorder
- Keywords
- Schizophrenia, Schizoaffective, Neuroimaging, Magnetic Resonance Imaging (MRI), Functional Magnetic Resonance Imaging (fMRI), Spectroscopy
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- University of Texas Southwestern Medical CenterUniversity, hospital or other
- Collaborators
- National Institute of Mental Health (NIMH)
- Study start
- Mar 2010
- Primary completion
- Apr 2029 (estimated)
- Study completion
- Apr 2029 (estimated)
- First posted
- 3 Aug 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Several observations have been made with magnetic resonance imaging (MRI) that characterize brain connections and brain function in individuals with schizophrenia and other mental disorders. For example, research investigating schizophrenia focuses on the dysfunction of connections within and between the medial temporal lobe and the prefrontal cortex as well as other pertinent brain regions. This database registry will allow for the collection of clinical interview data, behavioral data, blood, magnetic resonance imaging (MRI) data, and functional magnetic resonance imaging (fMRI) data on individuals with and without mental disorders to better understand how connections in the brain and various brain regions function differently while volunteers perform various cognitive tasks. This is an observational study that is being conducted to collect data and place it in a registry for current and future investigational questions related to imaging in mental disorders.
Detailed description
The proposed project entails the collection of clinical interview data, behavioral data, blood, magnetic resonance imaging (MRI) data, and functional magnetic resonance imaging (fMRI) data from 1000 volunteers, both patient volunteers and healthy normal volunteers. These data will be used for current and future investigations to better understand how the brains of those with mental disorders process differently that brains of healthy volunteers. The volunteers will undergo a series of clinical interviews to determine their diagnosis, behavioral task training, medical workup, and standard structural and functional magnetic resonance imaging. No changes will be made to the patient volunteers' medications or treatment regimes as part of the study. Data will be collected for all volunteer groups based on their performance on a variety of computer-mediated cognitive tasks. The volunteers will be trained to criteria on the tasks, at which point they will have the option to complete the MRI and fMRI portions of the study. Standard and functional MR images of the entire brain will be acquired while volunteers perform cognitive tasks thought to activate the medial temporal lobe and other pertinent brain regions. While participating in the task portion of the fMRI, visual stimulation (images) will be presented via back-projection from a high-resolution video projector (Epson 7000 series) with adjustable zoom. Volunteers will be asked to push a button on a handheld button box to record their responses as learned during training. For the non-task, resting portions of the fMRI, volunteers will be asked to stay relaxed and alert. In conjunction with one of the fMRI scans we will also conduct a cerebral blood volume (CBV) MRI to investigate blood perfusion in the medial temporal lobe of volunteers with mental illness to compare to normal control volunteers.
The proposed project will evaluate brain connectivity during cognitive tasks, including novelty detection, encoding and retrieval of associations between individual stimuli, and during other cognitive tasks thought to produce abnormal fMRI activations in volunteers with mental disorders. One example of a cognitive task is conducted as follows. Volunteers are shown a series of one-syllable nouns and asked to internally associate a second noun to the presented word (e.g. "station" to the presented word "train"). They press a response button when they have made a successful word association. Subsequently, volunteers are presented with a mixture of the previously encoded words and a new set of one-syllable nouns. Volunteers press one response button for previously presented words and another button for novel (new) words. fMRI scans for both parts of this task are acquired in the time between stimulus presentation and the press of the button. In another example of a cognitive task, volunteers are shown a novel series of faces paired with names and are instructed to remember the name for each face. In a subsequent period, volunteers attempt to remember which name goes to which face. The fMRI scans are acquired during both encoding and retrieval of the face-name pairs. These two described tasks are representative of the tasks to be used in terms of their difficulty and the effort required of the volunteers. In addition, "resting" and "control" tasks will be used to establish a baseline of brain activity against which we may then compare activity during our task of interest. Volunteers will receive instructions on task performance and will practice tasks prior to scanning in order to eliminate the novelty of the task itself as a potential confound. While the appointment time for a scan may take several hours, the volunteer will be in the scanner between 60 and 120 minutes depending on the specific memory task that is being administered at that visit. Any volunteer may receive training and be scanned on more than one task, but no volunteer will be kept in the scanner for longer than 120 minutes in any given session. Volunteers may also be asked to undergo one or two 60-minute MR Spectroscopy scans conducted on the 3Tesla (3T) or 7Tesla (7T) scanner. In this scan we will measure the levels of different brain compounds, such as neurotransmitters (e.g. glutamate, gamma aminobutyric acid [GABA]) or endogenous brain metabolites (e.g., N-acetyl -aspartate)in various brain regions, to non-invasively study tissue biochemistry.
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Patient volunteers | – | –This group is comprised of persons with Schizophrenia and Schizoaffective. |
| Healthy volunteers | – | –This group is comprised of individuals who have no current or past psychiatric diagnosis. |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Individuals who have been diagnosed with the following disorders will be enrolled in this study: Schizophrenia and Schizoaffective disorder.
Key inclusion criteria (11 listed)
- Volunteers with Schizophrenia or other mental illness
- Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) diagnosis of Schizophrenia or Schizoaffective disorder
- Competent to give informed consent
- All races and ethnicities
- Eyesight corrected to 20-40 or better
Key exclusion criteria (13 listed)
- Volunteers with schizophrenia or other mental illness
- Diagnosis of an organic brain disease
- Diagnosis of DSM-IV-TR alcohol or substance abuse within the last month or DSM-IV-TR alcohol or substance dependence within the last three months
- Serious, unstable medical illness
- History of serious head injury
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Differences in hippocampal subfield activation between people with schizophrenia (or schizoaffective disorder) and healthy volunteers
Time frame: Participants will be assessed over the course of 4-6 weeks, until all study procedures are complete
This study will investigate the alterations in the medial temporal lobe, specifically the differences in hippocampal subfield activation, between patients with psychosis (Schizophrenia and Schizoaffective disorder), their relatives and normal volunteers. We hypothesize that there will be an increase in perfusion and a decrease in subfield activation in the people with psychosis.
1 secondary outcome
Differences in glutamate neurotransmitters and glutamatergic function between people with schizophrenia (or schizoaffective disorder) and with healthy volunteers
Time frame: Participants will be assessed over the course of 4-6 weeks, until all study procedures are complete
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Apr 2026.
- Division of Translational Neuroscience Research in SchizophreniaLink provided by the sponsor.
Related trials for Schizophrenia
Recruiting
MI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMI
Schizophrenia Spectrum Disorders, Psychotic Affective Disorders
RecruitingObservational study
Tau Biomarkers in Late-onset Psychosis (LOP)
Late Onset Schizophrenia, Delusional Disorder (Late Onset)
Active, not recruitingObservational study
Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections
Severe Mental Illness, Inflammation
RecruitingPhase 3
Sequential Treatment Approaches for Treatment-Resistant Schizophrenia
Treatment-resistant Schizophrenia
Recruiting
REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
Schizophrenia, Schizo Affective Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Carol A. Tamminga, M.D. principal investigator
UT Southwestern
Elena Ivleva, M.D., Ph.D. principal investigator
UT Southwestern
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Schizophrenia and Schizoaffective Disorder, run by University of Texas Southwestern Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 11 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 23 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Elena Ivleva, M.D., Ph.D. (214-645-8942, elena.ivleva@utsouthwestern.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Differences in hippocampal subfield activation between people with schizophrenia (or schizoaffective disorder) and healthy volunteers (time frame: Participants will be assessed over the course of 4-6 weeks, until all study procedures are complete). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Apr 2026.